发明公开
- 专利标题: 2-PHENYLTHIOPHENE DERIVATIVE
- 专利标题(中): 2- PHENYLTHIOPHENDERIVAT
-
申请号: EP05774692申请日: 2005-08-26
-
公开(公告)号: EP1783124A4公开(公告)日: 2009-07-08
- 发明人: MIYATA JUNJI , YOKOTA MASAKI , NAITO RYO , KAMIKAWA AKIO , KAWAKAMI MASAKATSU , HATTORI KAZUYUKI
- 申请人: ASTELLAS PHARMA INC
- 专利权人: ASTELLAS PHARMA INC
- 当前专利权人: ASTELLAS PHARMA INC
- 优先权: JP2004249276 2004-08-27
- 主分类号: C07D333/40
- IPC分类号: C07D333/40 ; A61K31/381 ; A61K31/4025 ; A61K31/404 ; A61K31/41 ; A61K31/427 ; A61K31/4436 ; A61K31/4535 ; A61K31/5377 ; A61K31/541 ; A61K31/55 ; A61P1/00 ; A61P3/00 ; A61P3/10 ; A61P19/06 ; A61P43/00 ; C07D333/28 ; C07D409/04 ; C07D409/10 ; C07D409/12 ; C07D417/10 ; C07D417/12
摘要:
A 2-phenylthiophene derivative represented by the following general formula (I) or a salt thereof, characterized by comprising a thiophene ring substituted by a carboxy group, etc. and a benzene ring having both of an electron-attracting group, e.g., a cyano group, and an electron-donating group, e.g., a substituted alkoxy group. (I) The compound is satisfactory in xanthine oxidase inhibitory activity and uric acid lowering activity and has no structure derived from any nucleic acid. The compound hence has an advantage that it is safer and more effective than conventional compounds. The compound is useful as a therapeutic or preventive agent for hyperuricemia, gout, inflammatory intestinal diseases, diabetic nephropathy, diabetic retinopathy, etc.
信息查询